146 related articles for article (PubMed ID: 34336848)
1. Classification of Osteosarcoma Based on Immunogenomic Profiling.
Wang X; Wang L; Xu W; Wang X; Ke D; Lin J; Lin W; Bai X
Front Cell Dev Biol; 2021; 9():696878. PubMed ID: 34336848
[TBL] [Abstract][Full Text] [Related]
2. Classification of triple-negative breast cancers based on Immunogenomic profiling.
He Y; Jiang Z; Chen C; Wang X
J Exp Clin Cancer Res; 2018 Dec; 37(1):327. PubMed ID: 30594216
[TBL] [Abstract][Full Text] [Related]
3. Classification of Muscle-Invasive Bladder Cancer Based on Immunogenomic Profiling.
Zhou X; Qiu S; Nie L; Jin D; Jin K; Zheng X; Yang L; Wei Q
Front Oncol; 2020; 10():1429. PubMed ID: 32974156
[TBL] [Abstract][Full Text] [Related]
4. Classification of gastric cancers based on immunogenomic profiling.
Liu Z; Jiang Z; Wu N; Zhou G; Wang X
Transl Oncol; 2021 Jan; 14(1):100888. PubMed ID: 33096337
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Model Established by the Differential Expression Genes Based on CD8
Chen Y; Yan W; Wang H; Ou Z; Chen H; Huang Z; Yang J; Liu B; Ou F; Zhang H
Mediators Inflamm; 2023; 2023():6563609. PubMed ID: 36816742
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy.
Xu F; Chen JX; Yang XB; Hong XB; Li ZX; Lin L; Chen YS
Mol Ther Oncolytics; 2020 Jun; 17():241-249. PubMed ID: 32346613
[TBL] [Abstract][Full Text] [Related]
7. Immunogenomic Profiling and Classification of Prostate Cancer Based on HIF-1 Signaling Pathway.
Song J; Chen W; Zhu G; Wang W; Sun F; Zhu J
Front Oncol; 2020; 10():1374. PubMed ID: 32850440
[TBL] [Abstract][Full Text] [Related]
8. TYRO protein tyrosine kinase-binding protein predicts favorable overall survival in osteosarcoma and correlates with antitumor immunity.
Xu HR; Chen JJ; Shen JM; Ding WH; Chen J
Medicine (Baltimore); 2022 Sep; 101(39):e30878. PubMed ID: 36181123
[TBL] [Abstract][Full Text] [Related]
9. Hierarchical Clustering of Cutaneous Melanoma Based on Immunogenomic Profiling.
Yu J; Xie M; Ge S; Chai P; Zhou Y; Ruan J
Front Oncol; 2020; 10():580029. PubMed ID: 33330057
[TBL] [Abstract][Full Text] [Related]
10. Novel immune subtypes identification of HER2-positive breast cancer based on immunogenomic landscape.
Huang L; Liu X; Li L; Wang L; Wu N; Liu Z
Med Oncol; 2022 May; 39(5):92. PubMed ID: 35568771
[TBL] [Abstract][Full Text] [Related]
11. Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profiling.
Wei Y; Ou T; Lu Y; Wu G; Long Y; Pan X; Yao D
PeerJ; 2020; 8():e10414. PubMed ID: 33282564
[TBL] [Abstract][Full Text] [Related]
12. Autophagy-related gene expression classification defines three molecular subtypes with distinct clinical and microenvironment cell infiltration characteristics in colon cancer.
Zhu S; Wu Q; Zhang B; Wei H; Li B; Shi W; Fang M; Zhu S; Wang L; Lang Zhou Y; Dong Y
Int Immunopharmacol; 2020 Oct; 87():106757. PubMed ID: 32769067
[TBL] [Abstract][Full Text] [Related]
13. Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma.
Hu B; Wei Q; Zhou C; Ju M; Wang L; Chen L; Li Z; Wei M; He M; Zhao L
Int Immunopharmacol; 2020 Dec; 89(Pt A):107162. PubMed ID: 33168410
[TBL] [Abstract][Full Text] [Related]
14. Classification of serous ovarian carcinoma based on immunogenomic profiling.
Chen P; Zhang Y; Liang C; Yang Y; Li Y; Wan J
Int Immunopharmacol; 2021 Feb; 91():107274. PubMed ID: 33360087
[TBL] [Abstract][Full Text] [Related]
15. Development of a prognostic gene signature based on an immunogenomic infiltration analysis of osteosarcoma.
Yu Y; Zhang H; Ren T; Huang Y; Liang X; Wang W; Niu J; Han Y; Guo W
J Cell Mol Med; 2020 Oct; 24(19):11230-11242. PubMed ID: 32820615
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma.
Zong Y; Cao Y; Zhang D; Guan X; Zhang F; Shen Z; Yin F
Sci Rep; 2023 Jun; 13(1):9118. PubMed ID: 37277499
[TBL] [Abstract][Full Text] [Related]
17. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients.
Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ
Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792
[TBL] [Abstract][Full Text] [Related]
18. Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer.
Xiao Y; Ma D; Zhao S; Suo C; Shi J; Xue MZ; Ruan M; Wang H; Zhao J; Li Q; Wang P; Shi L; Yang WT; Huang W; Hu X; Yu KD; Huang S; Bertucci F; Jiang YZ; Shao ZM;
Clin Cancer Res; 2019 Aug; 25(16):5002-5014. PubMed ID: 30837276
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome-based molecular subtyping of non-small cell lung cancer may predict response to immune checkpoint inhibitors.
Jang HJ; Lee HS; Ramos D; Park IK; Kang CH; Burt BM; Kim YT
J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1598-1610.e3. PubMed ID: 31879171
[TBL] [Abstract][Full Text] [Related]
20. Identification of Two Novel Immune Subtypes Characterized by Distinct Prognosis and Tumor Microenvironment in Osteosarcoma.
Yao S; Deng M; Du X; Chen Q; Huang R
J Immunol Res; 2022; 2022():2181525. PubMed ID: 36254197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
